CMN-005 by CoImmune for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval

The latest development comes after the EMA CHMP provided a positive opinion recommending a grant of approval for the Keytruda regimen. Credit: Copyright © 2023

DENVER — Among Black/African American and Hispanic/Latino patients with relapsing multiple sclerosis (MS) in the phase IV CHIMES trial, half achieved a combined measure for

Compared with statins alone, upfront dual therapy with a statin and ezetimibe (Zetia) was associated with better survival in acute coronary syndrome, a Polish registry